{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:25:54Z","timestamp":1783416354637,"version":"3.54.6"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Colorectal cancer (CRC) is characterized by high incidence and mortality rates. Early identification of high-risk CRC patients and timely intervention are crucial for reducing mortality rates. This study aims to develop a prognostic model incorporating immune-related genes using 101 machine learning algorithms. We utilized data from 630 CRC patients in The Cancer Genome Atlas Program database and the Gene Expression Omnibus database as a validation set. We identified immune-related genes from the ImmPort repository and conducted differential gene expression analysis. We developed 101 machine learning models, including random survival forest, elastic net, LASSO, Ridge regression, stepwise Cox, Coxboost, partial least squares regression for Cox, supervised principal component analysis, generalized boosted modeling, and survival support vector machines. The model with the highest mean concordance index was selected as the optimal prognostic model. The Ridge regression model demonstrated the most robust performance with a mean concordance index of 0.67. Patients with higher immune-related gene risk score (IRGRS) had significantly lower survival rates (log-rank test,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Univariate and multivariate Cox regression analyses confirmed IRGRS as an independent prognostic factor. Nomograms successfully predicted overall survival at 1, 2, and 3 years. IRGRS correlated with immune cell infiltration levels and stromal activity in the tumor microenvironment. High IRGRS scores were associated with higher tumor immune dysfunction and exclusion scores, suggesting potential differences in response to immune checkpoint inhibitors. In addition, high IRGRS patients exhibited greater sensitivity to certain chemotherapy drugs. The IRGRS score is a potent predictor of survival in CRC patients. This study offers a new perspective for CRC prognosis and supports the development of personalized treatment strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048757","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:01:04Z","timestamp":1779469264000},"page":"e48757","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Survival prediction of colorectal cancer using 101 machine learning methods based on immune-related genes: A machine learning study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0849-2412","authenticated-orcid":false,"given":"Binyan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7350-8508","authenticated-orcid":false,"given":"Lei","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260707","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"R2-20260707","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/cancers12020319","article-title":"Prognostic and predictive molecular biomarkers for colorectal cancer: updates and challenges.","volume":"12","author":"Koncina","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12943-021-01441-4","article-title":"Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.","volume":"20","author":"Zhu","year":"2021","journal-title":"Mol Cancer"},{"key":"R4-20260707","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1101\/gad.293449.116","article-title":"Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.","volume":"31","author":"Boutin","year":"2017","journal-title":"Genes Develop"},{"key":"R5-20260707","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","article-title":"Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer.","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/1078-0432.CCR-14-0219","article-title":"New approaches but the same flaws in the search for prognostic signatures.","volume":"20","author":"Salazar","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.tranon.2024.101896","article-title":"Mitochondria-related chemoradiotherapy resistance genes-based machine learning model associated with immune cell infiltration on the prognosis of esophageal cancer and its value in pan-cancer.","volume":"42","author":"Liu","year":"2024","journal-title":"Transl Oncol"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/17425247.2021.1882992","article-title":"Research progress in tumor targeted immunotherapy.","volume":"18","author":"Fang","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"R9-20260707","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential.","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12967-020-02233-y","article-title":"IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis.","volume":"18","author":"Shi","year":"2020","journal-title":"J Transl Med"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"16679","DOI":"10.1038\/s41598-021-96373-w","article-title":"An immune cell infiltration-related gene signature predicts prognosis for bladder cancer.","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41575-024-01025-9","article-title":"Moving towards more personalized approaches in locally advanced and metastatic colorectal cancer.","volume":"22","author":"Sievers","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice.","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2217\/imt-2018-0002","article-title":"An overview of cancer immunotherapeutic strategies.","volume":"10","author":"Wahid","year":"2018","journal-title":"Immunotherapy"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers.","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition.","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"107591","DOI":"10.1016\/j.compbiomed.2023.107591","article-title":"Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis.","volume":"167","author":"He","year":"2023","journal-title":"Comput Biol Med"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy.","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"R19-20260707","doi-asserted-by":"crossref","first-page":"1368749","DOI":"10.3389\/fimmu.2024.1368749","article-title":"Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy.","volume":"15","author":"Qin","year":"2024","journal-title":"Front Immunol"},{"key":"R20-20260707","doi-asserted-by":"crossref","first-page":"16630","DOI":"10.1038\/s41598-024-67742-y","article-title":"Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response.","volume":"14","author":"Fu","year":"2024","journal-title":"Sci Rep"},{"key":"R21-20260707","doi-asserted-by":"crossref","first-page":"bbaa176","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response.","volume":"22","author":"Hu","year":"2021","journal-title":"Brief Bioinform"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nri2191","article-title":"CD1 antigen presentation: how it works.","volume":"7","author":"Barral","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R23-20260707","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment.","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"878365","DOI":"10.3389\/fimmu.2022.878365","article-title":"Recent advances in IL-13R\u03b12-directed cancer immunotherapy.","volume":"13","author":"Knudson","year":"2022","journal-title":"Front Immunol"},{"key":"R25-20260707","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/nu14091784","article-title":"CRABPs alter all-trans-retinoic acid metabolism by CYP26A1 via protein-protein interactions.","volume":"14","author":"Yabut","year":"2022","journal-title":"Nutrients"},{"key":"R26-20260707","doi-asserted-by":"crossref","first-page":"3764914","DOI":"10.1155\/2022\/3764914","article-title":"Diagnostic, prognostic, and immunological roles of FABP4 in pancancer: a bioinformatics analysis.","volume":"2022","author":"Yang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"R27-20260707","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"R28-20260707","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance.","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med"},{"key":"R29-20260707","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41597-023-02032-2","article-title":"Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer.","volume":"10","author":"Zhao","year":"2023","journal-title":"Sci Data"},{"key":"R30-20260707","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1038\/s41598-024-55919-4","article-title":"Machine learning developed a CD8(+) exhausted T cells signature for predicting prognosis, immune infiltration and drug sensitivity in ovarian cancer.","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"R31-20260707","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"R32-20260707","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy.","volume":"55","author":"Yang","year":"2023","journal-title":"Experimental Mol Med"},{"key":"R33-20260707","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"R34-20260707","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discovery"},{"key":"R35-20260707","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12943-024-02106-8","article-title":"Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications.","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"R36-20260707","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","article-title":"Cancer-associated fibroblasts in inflammation and antitumor immunity.","volume":"29","author":"Kennel","year":"2023","journal-title":"Clin Cancer Res"},{"key":"R37-20260707","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","article-title":"Interactions between coagulation and complement--their role in inflammation.","volume":"34","author":"Oikonomopoulou","year":"2012","journal-title":"Semin Immunopathol"},{"key":"R38-20260707","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat Med"},{"key":"R39-20260707","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.18632\/aging.205022","article-title":"Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer.","volume":"15","author":"Gong","year":"2023","journal-title":"Aging (Milano)"},{"key":"R40-20260707","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1038\/s41598-023-31153-2","article-title":"A novel immune score model predicting the prognosis and immunotherapy response of breast cancer.","volume":"13","author":"Lv","year":"2023","journal-title":"Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:01:49Z","timestamp":1783414909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":40,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048757","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2025-06-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}